Fri, January 20, 2023
Thu, January 19, 2023
Wed, January 18, 2023
Tue, January 17, 2023
Mon, January 16, 2023
Sat, January 14, 2023
Fri, January 13, 2023

Whitney Ijem Initiated (BMRN) at Hold and Held Target at $119 on, Jan 18th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. old-and-held-target-at-119-on-jan-18th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Whitney Ijem of Canaccord Genuity, Initiated "BioMarin Pharmaceutical Inc." (BMRN) at Hold and Held Target at $119 on, Jan 18th, 2023.

Whitney has made no other calls on BMRN in the last 4 months.



There are 7 other peers that have a rating on BMRN. Out of the 7 peers that are also analyzing BMRN, 2 agree with Whitney's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Andreas Argyrides of "Wedbush" Maintained at Hold with Increased Target to $83 on, Wednesday, January 11th, 2023
  • Luca Issi of "RBC Capital" Maintained at Hold with Increased Target to $95 on, Thursday, October 13th, 2022


These are the ratings of the 5 analyists that currently disagree with Whitney


  • Akash Tewari of "Jefferies" Maintained at Strong Buy with Increased Target to $120 on, Tuesday, November 29th, 2022
  • Leland Gershell of "Oppenheimer" Upgraded from Hold to Buy and Increased Target to $110 on, Monday, October 31st, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $113 on, Thursday, October 27th, 2022
  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $110 on, Thursday, October 27th, 2022
  • Jessica Fye of "JP Morgan" Maintained at Buy with Decreased Target to $112 on, Monday, October 24th, 2022

Publication Contributing Sources